Here We Go: Bill Gates-Funded Covid Vaccine Approved for Public Use by UK Regulatory Agency
SKYCovion
The SKYCovion COVID-19 vaccine, developed in South Korea with $3.6 million in funding from the Bill and Melinda Gates Foundation, recently received regulatory approval from the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA).
Source: Bill and Melinda Gates Foundation
“SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, has announced today the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted Marketing Authorization (MA) for SK bioscience’s COVID-19 vaccine SKYCovion
(brand name in Korea: SKYCovione) as a primary series for strong immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older,” according to the news release.
Once a vaccine receives Marketing Authorization,
